| |
|
|
|
Xtalks, Online
2024-09-09
Discover an informative webinar that addresses how the pharmaceutical industry can enhance trial accessibility and representation by encouraging clinical trial diversity.
Over the last few years, it has become clear that the pharmaceutical industry still has a lot of work to do to make clinical trials more inclusive, diverse and accessible to all patients. While Food and Drug Omnibus Reform Act of 2022 (FDORA) and the recent US Food and Drug Administration (FDA) draft guidance on diversity plans is a start, it is critical that pharmaceutical and biotech companies start thinking early about diversity initiatives — even before study recruitment begins!
In this webinar, the speakers bring together a diverse panel, including a patient advocate, community organizer and representatives from two top 10 pharmaceutical companies, to discuss the importance of activating local community leaders to build trust ahead of a specific clinical study. The panel will share their unique perspectives and outline two case studies, demonstrating how study teams practically implemented diversity, equity and inclusion (DE&I) initiatives to boost recruitment and retention.
The first case study details a unique grassroots, community activation approach that recruited African American women into their studies related to lupus. The second case study will showcase a video series that demonstrates the power of elevating diverse patient voices to build trust and inspire clinical trial participation.
Register for this webinar today to learn about successful community engagement and how the inclusion of different patient narratives is helping improve clinical trial diversity.
Keywords: Clinical Trials, Clinical Research, CRO, Patient Recruitment, Clinical Data, Regulatory, Patient Diversity, Clinical Trial Diversity, Diversity and Inclusion, Diversity and Inclusion in Clinical Trials
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
LaToya Bolds-Johnson, Breast Cancer Survivor, Patient Advocate
Kevin Aniskovich, CEO, Jumo Health
Tony Wafford, President & CEO, I Choose Life Foundation
Gwenn Oakes, Director, Global Trial Optimization, Merck
Michele Falk, Senior Manager, Patient Engagement & Recruitment Lead, Bristol Myers Squibb
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2024-09-09
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|